Marcin Frąckiewicz

Vanguard Total Stock Market ETF (VTI) Slides Despite $846 Million Inflows as Oil Shock Hits Wall Street

Vanguard Total Stock Market ETF (VTI) Slides Despite $846 Million Inflows as Oil Shock Hits Wall Street

Vanguard Total Stock Market ETF (VTI) fell 0.84% in premarket trading Monday after losing 1.45% over the past five days, despite $846 million in net inflows. U.S. equity funds shed $21.92 billion in the week to March 4 as oil surged and stock futures pointed lower. Major ETFs SPY and QQQ also traded down. VTI’s decline followed weakness in mega-cap tech and semiconductor stocks.
March 9, 2026
BlackRock Caps Private Credit Fund Withdrawals as Market Stress Spreads

BlackRock Caps Private Credit Fund Withdrawals as Market Stress Spreads

BlackRock capped withdrawals from its $26 billion HPS Corporate Lending Fund after clients sought $1.2 billion in redemptions, exceeding the fund’s 5% quarterly limit. The firm will fulfill about $620 million of requests, marking the first breach of the cap. BlackRock shares dropped 6.7% Friday. Fitch reported U.S. private-credit borrower defaults reached a record 9.2% in 2025.
March 9, 2026
Peraso stock cools after 151% spike on Israeli drone-defense win as cash strain remains

Peraso stock cools after 151% spike on Israeli drone-defense win as cash strain remains

Peraso Inc. shares dropped 3.9% to $1.96 in premarket trading Monday after soaring 151.5% Friday on news its mmWave chips were selected by Israeli defense firm InTACT for a drone IFF system. The company, facing cash concerns and exploring strategic options, did not disclose the program’s value or deployment timeline. Peraso ended September with $1.865 million in cash and warned of doubts about its ability to continue operating.
March 9, 2026
Olema Pharmaceuticals Shares Sink More Than 40% After Roche Trial Miss

Olema Pharmaceuticals Shares Sink More Than 40% After Roche Trial Miss

Olema Pharmaceuticals shares fell over 40% Monday after Roche’s breast cancer drug giredestrant failed to meet its main goal in a late-stage trial. Investors viewed the setback as a negative signal for Olema’s lead drug, palazestrant, which is in Phase 3 studies. Roche said the trial showed no significant improvement in progression-free survival. Olema ended September with $329 million in cash and expects top-line data in late 2026.
March 9, 2026
Xenon’s epilepsy drug posts strong Phase 3 data; XENE shares jump ahead of U.S. filing

Xenon’s epilepsy drug posts strong Phase 3 data; XENE shares jump ahead of U.S. filing

Xenon Pharmaceuticals said its Phase 3 trial showed azetukalner cut monthly focal onset seizures by 53.2% at the 25 mg dose versus 10.4% for placebo. Shares rose over 40% in premarket trading. The company plans to file for U.S. FDA approval in the third quarter of 2026. Dizziness was the most common side effect, with higher discontinuations in the 25 mg group.
March 9, 2026
Relmada Therapeutics (RLMD) Raises $160 Million as NDV-01 Bladder Cancer Data Set Up Phase 3

Relmada Therapeutics (RLMD) Raises $160 Million as NDV-01 Bladder Cancer Data Set Up Phase 3

Relmada Therapeutics will raise about $160 million in a private placement, priced at $4.75 a share, after reporting 12-month data showing a 76% complete response rate for NDV-01 in non-muscle invasive bladder cancer. The financing, expected to close by March 11, follows FDA feedback backing late-stage studies. NDV-01 showed no cases of disease progression or severe side effects among 25 patients at 12 months.
March 9, 2026
Oil Tops $100 for First Time Since 2022 as Iran War Cuts Supply, G7 Weighs Reserve Release

Oil Tops $100 for First Time Since 2022 as Iran War Cuts Supply, G7 Weighs Reserve Release

Brent crude surged to $119.50 a barrel Monday as the Iran war disrupted Gulf oil flows, forcing Saudi Arabia, Iraq, and Kuwait to cut output and leaving tankers stranded at the Strait of Hormuz. Central banks shifted rate expectations amid inflation fears. Governments considered releasing emergency reserves. Airline shares dropped as jet fuel prices soared.
March 9, 2026
Caterpillar stock slides 3.6% as oil spike shakes industrial bellwethers

Caterpillar stock slides 3.6% as oil spike shakes industrial bellwethers

Caterpillar shares fell 3.6% to $706.08 on Thursday, hitting a low of $693.81 amid rising oil prices and market volatility tied to Middle East tensions. The Dow dropped as much as 1,100 points, with Caterpillar and Goldman Sachs accounting for about 443 points of the decline. Deere & Co. also fell 3.8%. Caterpillar said it may need over 38,000 new technicians by 2028 as infrastructure demand grows.
March 6, 2026
Costco earnings beat as tariff refunds loom; CEO flags possible price cuts

Costco earnings beat as tariff refunds loom; CEO flags possible price cuts

Costco reported fiscal second-quarter net sales of $68.24 billion, up 9.1%, and net income of $2.04 billion, beating Wall Street estimates. CEO Ron Vachris said the company could cut prices if it receives refunds from struck-down Trump-era tariffs, but timing remains uncertain. A federal judge has ordered the U.S. government to begin refunding importers, with up to $182 billion at stake.
March 6, 2026
Strategy Inc Stock Drops as Bitcoin Rally Cools After $204 Million Buy

Strategy Inc Stock Drops as Bitcoin Rally Cools After $204 Million Buy

Strategy Inc shares fell 4.5% Thursday as bitcoin dropped 2.5% to about $70,880. A March 2 filing showed Strategy bought 3,015 bitcoin for $204.1 million, raising its holdings to 720,737 tokens. The company also increased the March annual dividend rate on its STRC preferred shares to 11.50% from 11.25%. Recent bitcoin declines left Strategy’s holdings worth about $3.7 billion less than its cost basis.
March 6, 2026
ServiceNow stock jumps after new EmployeeWorks, Autonomous Workforce push into government AI

ServiceNow stock jumps after new EmployeeWorks, Autonomous Workforce push into government AI

ServiceNow launched EmployeeWorks and an Autonomous Workforce suite for public sector clients, introducing its first Level 1 IT service desk AI specialist in controlled release. Shares climbed 5.8% to $120.38 after the announcement. The new tools target government agencies seeking to automate service desks and HR tasks. Broader rollout of the AI specialist is expected in Q2.
March 6, 2026
Intuit QuickBooks Index flags small-business job losses as U.S. payrolls report nears

Intuit QuickBooks Index flags small-business job losses as U.S. payrolls report nears

U.S. small businesses cut 45,300 jobs in February and average inflation-adjusted revenue fell 1.03% to $53,580, according to Intuit’s QuickBooks Small Business Index. Leisure and hospitality lost 11,300 jobs. The index draws on data from over 533,000 businesses and is adjusted to reflect broader trends. The government’s official February jobs report is due March 6.
March 6, 2026
XRP price today slips as Ripple expands Coinbase futures access and U.S. crypto bill stalls again

XRP price today slips as Ripple expands Coinbase futures access and U.S. crypto bill stalls again

XRP fell about 3% to $1.40 Thursday, with $2.8 billion traded and a market value near $86 billion, according to CoinMarketCap. Ripple said its Prime clients can now access Coinbase Derivatives contracts, including XRP futures, via Nodal Clear. Talks on the “Clarity Act” stalled in Washington as banks pushed for tighter crypto reward limits.
March 6, 2026
Eli Lilly’s $449 Zepbound play: new “Employer Connect” targets workplace coverage gap

Eli Lilly’s $449 Zepbound play: new “Employer Connect” targets workplace coverage gap

Eli Lilly launched “Employer Connect” to let U.S. employers offer its obesity drug Zepbound at network pharmacies for $449 per dose. Partners include GoodRx, Teladoc Health, and Mark Cuban Cost Plus Drug Company. Lilly shares fell about 2% after the announcement. The company said final out-of-pocket costs will depend on each employer’s cost-sharing model.
March 6, 2026
Booking Holdings stock jumps as OpenAI backs away from ChatGPT travel checkouts

Booking Holdings stock jumps as OpenAI backs away from ChatGPT travel checkouts

Booking Holdings shares jumped 8% after reports said OpenAI is scaling back direct travel bookings in ChatGPT, easing fears of AI bypassing online travel agencies. Expedia rose over 12% and Tripadvisor gained 5%. U.S. lawmakers pressed Booking.com and others for details on AI-driven “surveillance pricing.” Booking’s CFO said traffic from AI chatbots remains small.
March 6, 2026
1 31 32 33 34 35 102